Log in

AnaptysBio News Headlines (NASDAQ:ANAB)

$36.72
-0.32 (-0.86 %)
(As of 10/22/2019 09:29 AM ET)
Today's Range
$36.48
Now: $36.72
$37.76
50-Day Range
$30.97
MA: $38.33
$45.19
52-Week Range
$29.43
Now: $36.72
$87.49
Volume160,554 shs
Average Volume437,697 shs
Market Capitalization$993.28 million
P/E RatioN/A
Dividend YieldN/A
Beta1.5

Headlines

AnaptysBio (NASDAQ ANAB) News Headlines

Source:
DateHeadline
Did Changing Sentiment Drive AnaptysBios (NASDAQ:ANAB) Share Price Down A Worrying 53%? - Yahoo FinanceDid Changing Sentiment Drive AnaptysBio's (NASDAQ:ANAB) Share Price Down A Worrying 53%? - Yahoo Finance
finance.yahoo.com - October 20 at 12:13 PM
Did Changing Sentiment Drive AnaptysBio's (NASDAQ:ANAB) Share Price Down A Worrying 53%?Did Changing Sentiment Drive AnaptysBio's (NASDAQ:ANAB) Share Price Down A Worrying 53%?
finance.yahoo.com - October 20 at 12:12 PM
AnaptysBio Inc (NASDAQ:ANAB) Expected to Announce Quarterly Sales of $6.50 MillionAnaptysBio Inc (NASDAQ:ANAB) Expected to Announce Quarterly Sales of $6.50 Million
www.americanbankingnews.com - October 19 at 3:09 AM
 Brokerages Expect AnaptysBio Inc (NASDAQ:ANAB) to Announce -$1.17 EPS Brokerages Expect AnaptysBio Inc (NASDAQ:ANAB) to Announce -$1.17 EPS
www.americanbankingnews.com - October 17 at 1:13 PM
Investors Purchase High Volume of Call Options on AnaptysBio (NASDAQ:ANAB)Investors Purchase High Volume of Call Options on AnaptysBio (NASDAQ:ANAB)
www.americanbankingnews.com - October 17 at 9:23 AM
AnaptysBio Inc (NASDAQ:ANAB) Receives Average Rating of "Buy" from AnalystsAnaptysBio Inc (NASDAQ:ANAB) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - October 13 at 1:30 AM
Credit Suisse Group Reaffirms "Neutral" Rating for AnaptysBio (NASDAQ:ANAB)Credit Suisse Group Reaffirms "Neutral" Rating for AnaptysBio (NASDAQ:ANAB)
www.americanbankingnews.com - October 3 at 10:23 PM
AnaptysBio (ANAB) Looks Good: Stock Adds 8.1% in Session - Yahoo FinanceAnaptysBio (ANAB) Looks Good: Stock Adds 8.1% in Session - Yahoo Finance
finance.yahoo.com - October 3 at 4:27 PM
Heres Why AnaptysBio Stock Fell on TuesdayHere's Why AnaptysBio Stock Fell on Tuesday
www.nasdaq.com - October 3 at 1:39 AM
Wedbush: Investors Largely Underappreciating AnaptysBioWedbush: Investors Largely Underappreciating AnaptysBio
finance.yahoo.com - October 3 at 1:39 AM
The Daily Biotech Pulse: J&J Settles Ohio Opioid Lawsuit, Teligent Explores Options For Certain Assets, Novartis Reports Cosentyx DataThe Daily Biotech Pulse: J&J Settles Ohio Opioid Lawsuit, Teligent Explores Options For Certain Assets, Novartis Reports Cosentyx Data
finance.yahoo.com - October 2 at 3:37 PM
AnaptysBio Shares Drop Amid Questions About Phase II Participation Numbers - TheStreet.comAnaptysBio Shares Drop Amid Questions About Phase II Participation Numbers - TheStreet.com
www.thestreet.com - October 2 at 8:30 AM
Wedbush: Investors Largely Underappreciating AnaptysBio - BenzingaWedbush: Investors Largely Underappreciating AnaptysBio - Benzinga
www.benzinga.com - October 2 at 8:30 AM
Heres Why AnaptysBio Stock Fell on Tuesday - Motley FoolHere's Why AnaptysBio Stock Fell on Tuesday - Motley Fool
www.fool.com - October 1 at 10:28 PM
AnaptysBio Shares Drop Amid Questions About Phase II Participation NumbersAnaptysBio Shares Drop Amid Questions About Phase II Participation Numbers
finance.yahoo.com - October 1 at 5:27 PM
Investors Yawn As Biotech Puts Up Positive Test Results — For 2 PatientsInvestors Yawn As Biotech Puts Up Positive Test Results — For 2 Patients
finance.yahoo.com - October 1 at 5:27 PM
AnaptysBios (ANAB) "Outperform" Rating Reiterated at WedbushAnaptysBio's (ANAB) "Outperform" Rating Reiterated at Wedbush
www.americanbankingnews.com - October 1 at 9:51 AM
AnaptysBio (NASDAQ:ANAB) Given "Hold" Rating at Stifel NicolausAnaptysBio (NASDAQ:ANAB) Given "Hold" Rating at Stifel Nicolaus
www.americanbankingnews.com - September 30 at 10:41 PM
4 Stocks Moving In Mondays After-Hours Session - Benzinga4 Stocks Moving In Monday's After-Hours Session - Benzinga
www.benzinga.com - September 30 at 8:57 PM
AnaptysBio -13.5% after GALLOP trial data - Seeking AlphaAnaptysBio -13.5% after GALLOP trial data - Seeking Alpha
seekingalpha.com - September 30 at 8:57 PM
AnaptysBio Reports Positive Topline Data from Interim Analysis of GALLOP Phase 2 Clinical Trial of ANB019 Monotherapy in Moderate-to-Severe Generalized Pustular PsoriasisAnaptysBio Reports Positive Topline Data from Interim Analysis of GALLOP Phase 2 Clinical Trial of ANB019 Monotherapy in Moderate-to-Severe Generalized Pustular Psoriasis
finance.yahoo.com - September 30 at 8:57 PM
AnaptysBio to Present at the Cantor Fitzgerald Global Healthcare Conference - GlobeNewswireAnaptysBio to Present at the Cantor Fitzgerald Global Healthcare Conference - GlobeNewswire
www.globenewswire.com - September 27 at 7:10 AM
AnaptysBio to Present at the Cantor Fitzgerald Global Healthcare ConferenceAnaptysBio to Present at the Cantor Fitzgerald Global Healthcare Conference
finance.yahoo.com - September 27 at 7:10 AM
The Daily Biotech Pulse: Enanta Aces Midstage NASH Study, Takedas Ulcerative Colitis Drug Found Superior To AbbVies, Decision Day For J&J - Yahoo FinanceThe Daily Biotech Pulse: Enanta Aces Midstage NASH Study, Takeda's Ulcerative Colitis Drug Found Superior To AbbVie's, Decision Day For J&J - Yahoo Finance
finance.yahoo.com - September 26 at 4:09 PM
Chronic Rhinosinusitis with Nasal Polyps Pipeline Insight, 2019 Market Research Report - ResearchAndMarkets.com - BenzingaChronic Rhinosinusitis with Nasal Polyps Pipeline Insight, 2019 Market Research Report - ResearchAndMarkets.com - Benzinga
www.benzinga.com - September 17 at 7:08 PM
Biotech Stock On The Radar: Aimmune Awaits Adcom Test - BenzingaBiotech Stock On The Radar: Aimmune Awaits Adcom Test - Benzinga
www.benzinga.com - September 11 at 2:46 PM
ORIC Pharmaceuticals Appoints Dominic Piscitelli as Chief Financial Officer - Yahoo FinanceORIC Pharmaceuticals Appoints Dominic Piscitelli as Chief Financial Officer - Yahoo Finance
finance.yahoo.com - September 10 at 9:35 AM
Relative Strength Alert For AnaptysBio - NasdaqRelative Strength Alert For AnaptysBio - Nasdaq
www.nasdaq.com - August 23 at 6:27 PM
Is AnaptysBio (NASDAQ:ANAB) Using Debt Sensibly? - Yahoo FinanceIs AnaptysBio (NASDAQ:ANAB) Using Debt Sensibly? - Yahoo Finance
finance.yahoo.com - August 21 at 7:46 PM
Is AnaptysBio (NASDAQ:ANAB) Using Debt Sensibly?Is AnaptysBio (NASDAQ:ANAB) Using Debt Sensibly?
finance.yahoo.com - August 21 at 7:46 PM
Heres Why AnaptysBio Shares Are Slipping Today - Motley FoolHere's Why AnaptysBio Shares Are Slipping Today - Motley Fool
www.fool.com - August 20 at 6:48 PM
Here's Why AnaptysBio Shares Are Slipping TodayHere's Why AnaptysBio Shares Are Slipping Today
finance.yahoo.com - August 20 at 6:48 PM
AnaptysBio finance chief bids adieu - Seeking AlphaAnaptysBio finance chief bids adieu - Seeking Alpha
seekingalpha.com - August 19 at 6:31 PM
AnaptysBio Prepares for a Potential Gear ShiftAnaptysBio Prepares for a Potential Gear Shift
finance.yahoo.com - August 18 at 9:18 AM
AnaptysBio Prepares for a Potential Gear Shift - The Motley FoolAnaptysBio Prepares for a Potential Gear Shift - The Motley Fool
www.fool.com - August 11 at 9:35 AM
AnaptysBio Announces Second Quarter 2019 Financial Results and Provides Pipeline Updates - Yahoo FinanceAnaptysBio Announces Second Quarter 2019 Financial Results and Provides Pipeline Updates - Yahoo Finance
finance.yahoo.com - August 9 at 6:56 PM
AnaptysBio Announces Second Quarter 2019 Financial Results and Provides Pipeline Updates - GlobeNewswireAnaptysBio Announces Second Quarter 2019 Financial Results and Provides Pipeline Updates - GlobeNewswire
globenewswire.com - August 8 at 11:58 PM
AnaptysBio Announces Second Quarter 2019 Financial Results and Provides Pipeline UpdatesAnaptysBio Announces Second Quarter 2019 Financial Results and Provides Pipeline Updates
www.bloomberg.com - August 8 at 6:55 PM
AnaptysBio Announces Second Quarter 2019 Financial Results and Provides Pipeline UpdatesAnaptysBio Announces Second Quarter 2019 Financial Results and Provides Pipeline Updates
finance.yahoo.com - August 8 at 6:55 PM
AnaptysBio to Present at the Wedbush PacGrow 2019 Healthcare Conference - GlobeNewswireAnaptysBio to Present at the Wedbush PacGrow 2019 Healthcare Conference - GlobeNewswire
globenewswire.com - August 6 at 6:44 PM
AnaptysBio to Present at the Wedbush PacGrow 2019 Healthcare ConferenceAnaptysBio to Present at the Wedbush PacGrow 2019 Healthcare Conference
finance.yahoo.com - August 6 at 9:00 AM
The Week Ahead In Biotech: Focus On Earnings Deluge, Mid-Year Clinical Trial Readouts - Yahoo FinanceThe Week Ahead In Biotech: Focus On Earnings Deluge, Mid-Year Clinical Trial Readouts - Yahoo Finance
finance.yahoo.com - August 3 at 5:25 PM
Turning Point Therapeutics Names Carol Gallagher, Pharm.D. to its Board of Directors - Yahoo FinanceTurning Point Therapeutics Names Carol Gallagher, Pharm.D. to its Board of Directors - Yahoo Finance
finance.yahoo.com - July 25 at 10:06 AM
Biotech Braces for Busy Summer as 2019 M&A Volume Heats Up - BloombergBiotech Braces for Busy Summer as 2019 M&A Volume Heats Up - Bloomberg
www.bloomberg.com - July 3 at 5:38 PM
U.S. STOCKS ON THE MOVE-Sealed Air, Carnival Corp, Kroger, Micron - NasdaqU.S. STOCKS ON THE MOVE-Sealed Air, Carnival Corp, Kroger, Micron - Nasdaq
www.nasdaq.com - June 21 at 6:07 PM
AnaptysBio -3% as bull runs to sidelines - Seeking AlphaAnaptysBio -3% as bull runs to sidelines - Seeking Alpha
seekingalpha.com - June 21 at 11:53 AM
ContraVir Pharmaceuticals and Marker Therapeutics among healthcare gainers; Canopy Growth and AnaptysBio among losers - Seeking AlphaContraVir Pharmaceuticals and Marker Therapeutics among healthcare gainers; Canopy Growth and AnaptysBio among losers - Seeking Alpha
seekingalpha.com - June 21 at 11:53 AM
Does The AnaptysBio, Inc. (NASDAQ:ANAB) Share Price Tend To Follow The Market? - Yahoo FinanceDoes The AnaptysBio, Inc. (NASDAQ:ANAB) Share Price Tend To Follow The Market? - Yahoo Finance
finance.yahoo.com - June 21 at 11:53 AM
Does AnaptysBio, Inc. (NASDAQ:ANAB) Have A Volatile Share Price?Does AnaptysBio, Inc. (NASDAQ:ANAB) Have A Volatile Share Price?
finance.yahoo.com - June 21 at 11:53 AM
Does The AnaptysBio, Inc. (NASDAQ:ANAB) Share Price Tend To Follow The Market?Does The AnaptysBio, Inc. (NASDAQ:ANAB) Share Price Tend To Follow The Market?
finance.yahoo.com - June 21 at 11:53 AM
This page was last updated on 10/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel